Long-term remission in multiple myeloma—a blood cancer once considered incurable—is finally becoming a reality. A single ...

A man who survived blood cancer against the odds and lost two inches in height after suffering serious damage to his bones ...

Bouchard opened a discussion on sequencing therapies in MM, noting that CAR T-cell therapy and bispecific antibodies each ...

Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes ...

Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) ...

As September concludes, the landscape of hematologic oncology continues to evolve, spanning the full spectrum of blood cancer ...

As many as one third of newly diagnosed multiple myeloma (MM) cases are classified as high risk, with widely varying rates of ...

A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and ...

A man in London thought he had injured his back, only to find out he has an incurable form of blood cancer. Terry Harper, 62, ...

The U.S. Food and Drug Administration on Friday approved labeling changes for Johnson & Johnson and its partner Legend ...

He recalled his co-stars lovingly visiting him, with Tracey Bregman (Lauren) dropping by with tea and crumpets, and podcast ...